0001213900-24-074517.txt : 20240830
0001213900-24-074517.hdr.sgml : 20240830
20240830160512
ACCESSION NUMBER: 0001213900-24-074517
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240812
FILED AS OF DATE: 20240830
DATE AS OF CHANGE: 20240830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Czuczman Myron
CENTRAL INDEX KEY: 0001817716
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41534
FILM NUMBER: 241269855
MAIL ADDRESS:
STREET 1: C/O CITIUS PHARMACEUTICALS, INC.
STREET 2: 11 COMMERCE DRIVE, 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CITIUS ONCOLOGY, INC.
CENTRAL INDEX KEY: 0001851484
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
BUSINESS PHONE: (908) 967-6677
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVE,
STREET 2: SUITE 2446
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: TenX Keane Acquisition
DATE OF NAME CHANGE: 20210315
4/A
1
ownership.xml
X0508
4/A
2024-08-12
2024-08-14
0
0001851484
CITIUS ONCOLOGY, INC.
CTOR
0001817716
Czuczman Myron
C/O CITIUS ONCOLOGY, INC.
11 COMMERCE DRIVE, 1ST FLOOR
CRANFORD
NJ
07016
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
2.15
2024-08-12
4
A
0
1400000
0
A
2033-07-05
Common Stock
1400000
1400000
D
This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
This Form 4 has been amended to correct the amount of option shares held by the Reporting Person.
/s/ Lorna A. Knick, by Power of Attorney
2024-08-30